The most common age of onset for anxiety disorders is in adolescence and young adulthood and can put youth at risk for failure to meet academic, social, and occupational milestones, or for developing depression and substance use if not properly treated. Cognitive behavioral therapy with exposure therapy has been identified as the frontline treatment, however a substantial number of patients do not get better or experience relapse. Dr. Pelcovitz will discuss her current research, focusing on enhancing existing therapies by integrating cutting edge technology.
Watch webinar recording:
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.